Ngôn ngữ sử dụng
Cách trích dẫn
Tóm tắt
Objectives: To describe clinical and subclinical characteristics, to determine the clinical pregnancy rate, and to analyze some factors related to in vitro fertilization (IVF) outcomes in women with polycystic ovary syndrome (PCOS) at Can Tho Gynecology Obstetrics Hospital.
Materials and methods: A cross-sectional descriptive study was conducted on 95 infertile women diagnosed with PCOS according to Rotterdam criteria, underwent IVF cycles at the Fertility department of Can Tho Gynecology Obstetrics hospital from April 2023 to September 2023. The baseline characteristics of PCOS were described and IVF outcomes of research subjects were evaluated. Some factors related to clinical pregnancy rate were also analyzed.
Results: The average age of the study subjects was 29.9 ± 4.5 years old. The overweight rate was 11.6%. The symptoms of women with PCOS include hyperandrogenism (16.8%); oligomenorrhea (71.6%), and amenorrhea (1.1%); The image of polycystic ovaries on ultrasound in 1 ovary was 14.7%, whereas in 2 ovaries was 72.6%. The average AMH concentration was 6.8 ± 4.4 ng/ml. Primary infertility and secondary infertility accounted for 58.9% and 41.1% respectively. The βhCG (+) rate and clinical pregnancy rate were 62.1% and 57.9%, respectively. The rate of ovarian hyperstimulation was 8.4% (8 cases), of which mild ovarian hyperstimulation was 75% and moderate severity was 25%. The multiple pregnancy rate was 38.2%, and the miscarriage rate was 2.1%. There was no statistically significant difference between the clinical pregnancy rate and several factors such as age, BMI, type of infertility, hyperandrogenism, number of follicles aspirated, number of embryos transferred to the uterus, number of day-3 embryos, number of day-5 embryos, ovarian hyperstimulation.
Conclusion: Women with PCOS have common characteristic disorders such as menstrual disorders, hyperandrogenism, and polycystic ovary images on ultrasound. Research showed that the clinical pregnancy rate in women with PCOS undergoing IVF was 57.9%.
Tài liệu tham khảo
2. Phượng, N.T.N., 20 năm thụ tinh trong ống nghiệm tại Việt Nam 1997-2017. Tạp chí Y học sinh sản, 2017. 43: p. 5-6.
3. Rotterdam ESHRE/ASRM, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004. 81(1): p. 19-25.
4. Yu, R., et al., Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Zhonghua Fu Chan Ke Za Zhi, 2012. 47 (4): p. 250-254.
5. Vũ, H.N.A., The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count. Hum Reprod, 2019. 34(6): p. 1055-1064.
6. Shalom-Paz, E., et al., PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol, 2012. 165(1): p. 53-56.
7. Lan, V.T.N., et al., Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial". Reprod Biomed Online, 2019. 38(3): p. 387-396.
8. Zheng, Z., et al., Multiple pregnancies achieved with IVF/ICSI and risk of specific congenital malformations: a meta-analysis of cohort studies. Reprod Biomed Online, 2018. 36 (4): p. 472-482.
9. Sa, L.V.N., Ảnh hưởng của các kiểu hình Hội chứng buồng trứng đa nang khác nhau lên kết quả thụ ti trong ống nghiệm. Tạp chí Phụ sản, 2021. 19(1): p. 54-60.
10. Tường, H.M., Hội chứng buồng trứng đa nang. Tạp chí Y học sinh sản, 2017. 43: p.7-8.
11. Tường, H.M., Đ.Q. Vinh and V.T.N. Lan, Thụ Tinh trong ống nghiệm, lịch sử, hiện tại và tương lai, Thụ tinh trong ống nghiệm, Nhà xuất bản giáo dục Việt Nam, 2021. p. 3-26.
12. Tâm, L.M., Rối loạn nội tiết sinh sản ở bệnh nhân vô sinh có hội chứng buồng trứng đa nang. Tạp chí Phụ sản, 2015. 15(03):p. 119-125.
Công trình này được cấp phép theo Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. .